DC Chemicals

All products / DC8731

Lesinurad sodium
CAT. NO. DC8731

Lesinurad sodium

Pack sizes and prices

Pack sizePrice
100 mg$200 USDRequest a quote →
250 mg$400 USDRequest a quote →
1 g$800 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

Lesinurad sodium is a URAT1 and OAT inhibitor, is determined to be a substrate for the kidney transporters OAT1 and OAT3 with Km values of 0.85 and 2 µM, respectively.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC8731
Product nameLesinurad sodium
CAS1151516-14-1
Molecular formulaC17H13BrN3NaO2S
Molecular weight426.2628
Purity>98%
SMILESBrC1=NN=C(N1C1=C([H])C([H])=C(C2=C([H])C([H])=C([H])C([H])=C21)C1([H])C([H])([H])C1([H])[H])SC([H])([H])C(=O)[O-].[Na+]

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — Lesinurad sodium (DC8731)

Source references

[1]. Shen Z, et al. In Vitro and In Vivo Interaction Studies Between Lesinurad, a Selective Urate Reabsorption Inhibitor, and Major Liver or Kidney Transporters. Clin Drug Investig. 2016 Jun;36(6):443-52. [2]. Sattui SE, et al. Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications. Ther Adv Musculoskelet Dis. 2016 Aug;8(4):145-59. [3]. L.Yeh, et al. RDEA594, a potential uric acid lowering agent througn inhibition of uric acid reuptake ,shows better pharmacokinetics rhan its prodrug RDEA806. 2008 ACR/ARHP Annual Scientific Meeting, 24-29 October 2008, USA.

Related research products